SCHEMBL885750

SCHEMBL885750

O=C(O)N1CCN(C(=O)c2[nH]c(=O)n(-c3ccccc3)c2CC2CC2)CC1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 5/20 0.39
HSD17B10 Q99714 4/20 0.39
ALDH1A1 P00352 4/20 0.39
MEN1 O00255 2/20 0.39
HPGD P15428 2/20 0.39
KMT2A Q03164 2/20 0.39
GLA P06280 1/20 0.39
GAA P10253 1/20 0.39
MAPT P10636 1/20 0.38
SMN1; SMN2 Q16637 2/20 0.37
MGLL Q99685 2/20 0.37
USP2 O75604 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
MAPK10 P53779 1/20 0.37
CYP2C9 P11712 3/20 0.36
CYP2C19 P33261 3/20 0.36
MAPK14 Q16539 3/20 0.36
HTR2B P41595 2/20 0.36
GRIN2D O15399 1/20 0.35
GRIN3B O60391 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2062746 0.90 REN (0.45)
SCHEMBL8164967 0.85 GPR119 (0.47) MEN1KMT2AMAPT
SCHEMBL886271 0.84 MAT2A (0.39) LMNAHSD17B10ALDH1A1MEN1KMT2A
SCHEMBL885738 0.80 ALDH1A1 (0.41) LMNAHSD17B10ALDH1A1MEN1HPGD
SCHEMBL885771 0.79 MAT2A (0.48) LMNAALDH1A1MEN1HPGDKMT2A
SCHEMBL2063853 0.77 ALDH1A1 (0.42) LMNAHSD17B10ALDH1A1MEN1HPGD
SCHEMBL885673 0.72 ALOX5 (0.43) LMNAHSD17B10ALDH1A1MEN1HPGD
SCHEMBL885974 0.72 LMNA (0.40) LMNAHSD17B10ALDH1A1MEN1HPGD
SCHEMBL885971 0.70 ALDH1A1 (0.47) LMNAALDH1A1MEN1KMT2AGAA
SCHEMBL2062901 0.69 SIGMAR1 (0.47) LMNAHSD17B10ALDH1A1MEN1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008089005-A2 RENIN INHIBITORS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2008-07-24 WO claimed
US-8148367-B2 Renin inhibitors TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2012-04-03 US disclosed
US-20100105665-A1 RENIN INHIBITORS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2010-04-29 US disclosed
WO-2008089005-A2 RENIN INHIBITORS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2008-07-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100105665-A1 RENIN INHIBITORS REN, ACE, AGT LMNA 824/4885HSD17B10 873/4885ALDH1A1 947/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.